Competition & Peer Data API & CSV Delivery

Syra Health's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Syra Health (SYRA) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
36.60 %
Q2 2026
Net Margin
10.45 %
Q2 2026

Key Findings: Syra Health vs Its Competitors

  • TTM: Trailing 12-month revenue of 8M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+27.5% annualized vs trailing 12 months).
  • Scale: Syra Health ranks #3 of 4 companies by market capitalization in the Employment Agencies industry, holding 0.3% of industry market cap.
  • Peer revenue share: Syra Health accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

SYRA Sales vs. its Competitors, Q2 2026

Syra Health generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/SYRA/competitors
https://api.csimarket.com/api/v1/companies/SYRA/relationships
https://api.csimarket.com/api/v1/companies/SYRA/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Employment Agencies industry grew revenue 5.1% year over year, combined, vs 36.6% for Syra Health. Syra Health's share of combined industry revenue moved from 0.11% to 0.14%, a gain of 0.03 percentage points.

Syra Health's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Syra Health Corp Yes Yes Yes No
Similar-Size Competitors (2) 50% 50% 0% 0%
Similar Growth & Profitability (4) 50.00 % (2 of 4) 50.00 % (2 of 4) 25.00 % (1 of 4) 25.00 % (1 of 4)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

100%market share
  • Syra Health100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Syra Health and its 0 tracked competitors.

See Syra Health's full market share breakdown »

SYRA Stock Performance relative to its Competitors

SYRA Competitors (weighted) Percent change over the selected range

Syra Health's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
33.3%beat U.S.A. 500
Similar-Size
(1 of 3)
66.7%beat U.S.A. 500
Similar Growth & Profitability
(2 of 3)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Syra Health Corp 710.00 % Outperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (3) 40.4% 63.2%
Similar Growth & Profitability (3) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Syra Health's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

SYRA Stock Performance relative to Similar-Size Competitors

SYRA Similar-Size Competitors (equal-weighted, 3) Percent change over the selected range

SYRA Stock Performance relative to Similar Growth & Profitability Competitors

SYRA Similar Growth & Profitability Competitors (equal-weighted, 4) Percent change over the selected range

Syra Health's Comment on Competition and Industry Peers

The competitive landscape involves challenges including competition within the healthcare industry, timing and cost of new product and service introductions, development and product upgrade releases, competitive pressures related to offerings and pricing, and the ability to establish and maintain strategic relationships. Additional factors include undetected errors in software products, compliance with laws and regulations, potential liabilities, protection of intellectual property rights, reliance on third-party content providers, and the success of competitors.